Bibliography
- Hohmann AG, Suplita RL. Endocannabinoid mechanisms of pain modulation. AAPS J 2006;8(4):E693-708
- Boyd ST. The endocannabinoid system. Pharmacotherapy 2006;26:218S-221S
- Brown AJ. Novel cannabinoid receptors. Br J Pharmacol 2007;152(5):567-75
- Campbell FA, Tramer MR, Carroll D, et al. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001;323:1-6
- Iskedjian M, Bereza B, Gordon A, et al. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin 2007;23:17-24
- Perez J. Combined cannabinoid theraphy via an oromucosal spray. Drugs Today 2006;42:495-503
- GW Pharmaceutical website. News and media page. 2007. Available from: www.gwpharm.com/news_press_releases.asp [Accessed October 2007]
- Merksey H, Bogduk N, editors, Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd edition. Seattle: IASP Press; 1994
- Attal N, Cruccu G, Haanp M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-69
- Butera JA. Recent approaches in the treatment of neuropathic pain. J Med Chem 2007;50:2543-6
- O'Shaugnessy WB. On the preparations of the Indian hemp, or gunjah. Med Phys Soc Beng 1838;40:71-102
- O'Shaugnessy WB. Med Phys Soc Beng 1842:421-61
- The British Medical Association website. Medical care section: therapeutic uses of cannabis, the 1997 report presented by the Clinical Cannabinoid Group. Available from: www.bma.org.uk/ap.nsf/Content/Therapeuticcannabis [Accessed October 2007]
- Blake DR, Robson P, Ho M, et al. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 2006;45:50-2
- Russo EB, Guy GW, Robson PJ. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 2007;4:1729-43
- Solaro C, Tanganelli P, Messmer Uccelli M. Pharmacological treatment of pain in multiple sclerosis. Exp Rev Neurother 2007;7:1165-74
- Notcutt W, Price M, Miller R, et al. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 ‘N of 1’ studies. Anaesthesia 2006;59:440-52
- Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005;65:812-9
- Rog DJ, Nurmikko TJ, Friede T, Young CA. Oromucosal D9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther 2007;29:2068-79
- Wade DT, Makela PM, House H, et al. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler 2006;12:639-45
- Yoshikawa T, Hayashi N, Yamamoto S, et al. Brachial lexus injury: clinical manifestations, conventional imaging findings, and the latest imaging techniques. Radiographics 2006;26:133-43
- Berman J, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 2004;112:299-306
- Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003;102:1-8
- Nurmikko TJ, Serpell MG, Hoggart B, et al. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 2007;133:210-20
- Keizer D, Van Wijhe M, Post WJ, et al. Assessment of the clinical relevance of quantitative sensory testing with Von Frey monofilaments in patients with allodynia and neuropathic pain. A pilot study. Eur J Anaesthesiol 2007;24:658-63
- Moore A, Mcquay HJ. Bias. Bandolier Internet J 2000;7:1-5. Free internet access. Available from: www.jr2.ox.ac.uk/bandolier/painres/download/Bando080.pdf
- Lienau FS, Fullgraf H, Moser A, Feuerstein TJ. Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis? Eur J Neurol 2007;14:1162-9
- Farrar JT. What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain 2000;16:S106-12
- Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:849-63
- Di Forti M, Morrison PD, Butt A, Murray RM. Cannabis use and psychiatric and cognitive disorders: the chicken or the egg? Curr Opin Psychiatry 2007;20:228-34
- Scully C. Cannabis;adverse effects from an oromucosal spray. Br Dent J 2007;22:E12